2017
DOI: 10.1016/j.ijom.2017.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Do antiplatelet drugs increase the risk of bleeding after tooth extraction? A case-crossover study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…A case-crossover study by Akhlaghi et al in 2017 assessed whether there is indeed a higher risk in these patients who underwent surgery. However, the result was that dental extractions could be addressed without modifying aspirin or clopidogrel therapy, despite some differences between the groups assessed in platelet reactivity and clot formation [40]. The bleeding was measured in patients by performing dual antiplatelet therapy after oral surgery by Medeiros et al, and in patients with dual antiplatelet therapy no complications were noted, so it was not necessary to stop the treatment [41].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A case-crossover study by Akhlaghi et al in 2017 assessed whether there is indeed a higher risk in these patients who underwent surgery. However, the result was that dental extractions could be addressed without modifying aspirin or clopidogrel therapy, despite some differences between the groups assessed in platelet reactivity and clot formation [40]. The bleeding was measured in patients by performing dual antiplatelet therapy after oral surgery by Medeiros et al, and in patients with dual antiplatelet therapy no complications were noted, so it was not necessary to stop the treatment [41].…”
Section: Discussionmentioning
confidence: 99%
“…The dentist, even in patients undergoing therapy, can perform routine extraction without risk without interrupting or modifying the latter. Patients do not have a greater risk of bleeding, even if they have been in antiplatelet therapy for a long time but, in some cases, as some authors mention in a refined way, the therapy must be personalized for each patient [26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42] Pototski et al in 2007, stated in their work that patients can be treated without risk if their INR is lower than 4.0 [48]. However, other studies assess that the risk of bleeding can be controlled by post-extraction hemostasis maneuvers [49].…”
Section: Discussionmentioning
confidence: 99%
“…This supports the results of similar studies conducted on patients undergoing other dental surgeries, such as surgical and nonsurgical tooth extraction. 3,7 In patients using antiplatelet drugs, the risk of surgical site bleeding should always be compared against the risk of thrombotic events. Studies of patients with coronary artery disease and at risk of ischemic stroke have shown that ASA withdrawal seriously increases the risk of adverse cardiac and brain ischemic events.…”
Section: Discussionmentioning
confidence: 99%
“…But still controversies remains whether to stop or continue anti-platelet therapy. [ 1 ] The clinician must balance the risk of thromboembolism by reducing or stopping antiplatelet therapy against the risk of triggering excessive post extraction bleeding if antiplatelet therapy is maintained at therapeutic levels during surgery. Aspirin is frequently used antiplatelet drugs which belongs to the non-steroidal anti-inflammatory drugs.…”
Section: Introductionmentioning
confidence: 99%